| April L Marquardt, MD | |
|
4990 W Clark Rd, Suite 300, Ypsilanti, MI 48197-1149 | |
| (734) 593-5990 | |
| (734) 593-5995 |
| Full Name | April L Marquardt |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 21 Years |
| Location | 4990 W Clark Rd, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235352311 | NPI | - | NPPES |
| 2844088 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Opening Act?" by John Deering.
Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.
A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report.
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
› Verified 3 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Opening Act?" by John Deering.
Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.
A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report.
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
› Verified 3 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Opening Act?" by John Deering.
Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.
A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report.
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April L Marquardt, MD 24 Frank Lloyd Wright Dr Lbby J2000, Ann Arbor, MI 48105-9484 Ph: () - | April L Marquardt, MD 4990 W Clark Rd, Suite 300, Ypsilanti, MI 48197-1149 Ph: (734) 593-5990 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Opening Act?" by John Deering.
Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.
A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report.
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
› Verified 3 days ago
Bretton Lee Schloesser, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Dr. Kelly Perry Apple, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855 | |
Rajiv Doddamani, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270 | |
Dr. James Paolo Purtell, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552 | |
Kory Ashton Strong, DO Rheumatology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Michael Sanson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665 | |
Dr. Stephanie Joy-kraftson Hoffman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012 |